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beamlets that would deliver dose to the target after passing a 
prosthesis (IMRTremove, recommended by AAPM), and ii) exclusion of 
only those beamlets including a 5 mm margin (IMRTcut). Plans with 
optimized coplanar and non-coplanar beam arrangements were 
generated. Differences in PTV coverage and sparing of organs at risk 
(OARs) were quantified. The impact of beam number on plan quality 
was evaluated. 
Results: Especially for patients with bilateral hip prostheses, IMRTcut 
significantly improved rectum and bladder sparing compared to 
IMRTremove. For 9-beam coplanar plans, rectum V60Gy reduced by 17.5% 
± 15.0% (maximum 37.4%, p = 0.036) and rectum Dmean by 9.4% ± 7.8% 
(maximum 19.8%, p = 0.036). PTV coverage was similar, except for 
one patient who had a V95% of only 22.3% for IMRTremove, compared to 
99.1% for IMRTcut. Improved PTV coverage was only possible with a 
higher dose in all OARs (see figure). Further improvements in OAR 
sparing were achieved by using non-coplanar beam set-ups, reducing 
rectum V60Gy by another 4.6% ± 4.9% (p = 0.012) for non-coplanar 9-
beam IMRTcut plans. Large reductions in rectum dose delivery were 
also observed when increasing the number of optimized beam 
directions in the plans. For bilateral implants, rectum V60Gy was 37.3% 
± 12.1% for coplanar 7-beam IMRTcut plans which reduced on average 
by 13.5% (maximum 30.1%, p = 0.012) for 15 optimized beam 
directions. 
Conclusions: For prostate cancer patients with metal hip implants, 
iCycle was able to automatically generate high quality, patient-
specific IMRT plans with optimized coplanar or non-coplanar beam 
arrangements. Excluding only beamlets that would deliver dose to the 
PTV after passing through a prosthesis significantly improved OAR 
sparing for patients with bilateral implants as opposed to the AAPM 
taskgroup 63 recommendation. Non-coplanar beam arrangements and, 
to a larger extent, increasing the number of optimized treatment 
beams further improved plan quality. 
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Purpose/Objective: Stereotactic body radiotherapy (SBRT) for non-
small-cell lung cancer (NSCLC) has led to promising local control and 
overall survival for fractionation schemes with increasingly high 
fractional doses. A point has however been reached where too few 
fractions may be used to allow efficient inter-fraction reoxygenation 
(IFR) of the hypoxic cells possibly residing in the tumours. It was the 
purpose of this study to investigate the impact of hypoxia and 
extreme hypofractionation on the tumour control probability (TCP) 
using realistic 3D-models of tumour oxygenation. 
Materials and Methods: 3D-models of tumour oxygenation have been 
based on previous calculations of tumour oxygenation at cellular level 
for various distributions of intervascular distances. The models took 
into account dynamic changes in the oxygenation of the tumours 
between fractions. Simulations were performed for currently used 
fractionation schemes for NSCLC and for theoretical dose prescriptions 
that may be used in SBRT. Clinically relevant dose distributions were 
used to ensure the fulfilment of prescription details for dose 
escalation, dose to the PTV periphery and maximum dose. Cellular 
response was assessed with the LQ model at voxel level and a Poisson 
TCP model at tumour level. 
Results: Calculated tumour control probabilities with IFR agree best 
with reported clinical local control for multi-fraction schemes (Table 
1). The largest disagreement between the clinical figures and the 
calculated values are seen for the single-fraction schemes which could 
be caused by other biophysical processes believed to take place at 
high doses, but not included in the model, such as vascular 
endothelial apoptosis.TCP curves for 1, 3 and 5 fractions with and 
without IFR (Figure 1) demonstrate the importance of allowing for IFR. 
Furthermore, they suggest that 3 or 5 fractions are enough to ensure 
IFR. 
 
Table 1. Examples of calculated TCP with and without IFR for the 
dose schemes pertinent to current clinical practice in the SBRT 
treatment of NSCLC with clinical figures of survival and local control. 
Normal- and tumour tissue BED:s are also given.  
 
† Dose range 24-40 Gy, 69% was given 37.5Gy  
‡ Based on 60 Gy totaldoses given in 3, 5 and 8 fractions: 3x20 
Gy(33%), 5x12 Gy (50%), 8x7.5 Gy(17%) 
 
 
 
Conclusions: Single-fraction stereotactic treatments may require a 
considerable increase in dose per fraction, well above fractional doses 
used today, to counteract the radioresistance of hypoxic cells. 
Although attractive from an economical and practical viewpoint, 
extreme hypofractionation in SBRT should therefore be pursued with 
caution as the reduced possibility for IFR may result in impaired local 
control.  
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Purpose/Objective: One of the worst radiation induced acute effects 
in treating head-and-neck (HN) cancer is grade 3 or higher acute (oral 
and pharyngeal) mucosal toxicity(AMT), caused by the killing/ 
depletion of mucosa cells. Late toxicity are reported after altered 
radiotherapy schedules. The paper aims attesting a predictive model 
of the AMT, as well as late toxicity, in HN cancer patients receiving 
different radiotherapy schedules. 
Materials and Methods: Various radio-therapeutic schedules have 
been reviewed and classified as tolerable or intolerable based on AMT 
 
Dose 
prescr. 
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Treatment outcome TCP (%) 
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Local 
control 
No 
reox IFR 
3x12.5 
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60% 
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193.8 84.4 
80% at 1 
year† 
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100% at 1 
year† 
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(Stage 
1A/1B) 
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(Stage 
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8x7.5 Gy,
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85.7% at 1 
year‡ 
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years‡ 
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years‡ 0 100
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severity. A modified normal tissue complication probability (NTCP) 
model has been investigated to describe AMT data in radiotherapy 
regimes, both conventional and altered in dose and overall treatment 
time (OTT). We tested the hypothesis that such a model can also be 
applied to identify intolerable treatment and predict AMT and late 
toxicity. NTCP model has been compared with other published 
predictive models to identify schedules that are either tolerable or 
not. The Area Under Curve (AUC) was calculated for all models 
assuming treatment tolerance as the gold standard. NTCP model for 
late effect was also calculated. The correlation between AMT/late 
toxicity and the predicted toxicity rate was assessed by a Pearson 
correlation test. 
Results: The AMT NTCP model was able to distinguish between 
acceptable and intolerable schedules among the data available for the 
study(AUC=0.84,95%CI:0.75-0.92). In the equivalent dose at 
2Gy/fraction(EQD2) versus OTT space, the proposed model shows a 
similar trend to that of models proposed by other Authors, but was 
superior in detecting some intolerable schedules. Moreover, it was 
able to predict the incidence of ≥G3 AMT. A correlation between the 
modified late NTCP model and ≥G3 late toxicity has been found as 
trend (p=0.07). 
Conclusions: The proposed acute NTCP model is able to predict ≥G3 
AMT after HN cancer radiotherapy and could be useful for designing 
altered/ hypofractionated schedules in order to reduce the incidence 
of AMT. Late NTCP model was able to predict late toxicity but 
requires further improvements to increase the predictive power.  
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Purpose/Objective: Current models for toxicity prediction in prostate 
cancer radiotherapy are based on the dose-volume histograms which 
lack of spatial accuracy. The goal is to propose new methods able to 
predict late rectal bleeding following high-dose prostate cancer 
radiotherapy. The aim is to fully exploit the tri-dimensional planned 
Dose Distribution (pDD) to study the correlation with rectal toxicity. 
Materials and Methods: A total of 63 patients having received a dose 
of 80Gy in the prostate by IMRT have been included in the study. 
Twelve of them presented rectal bleeding (> grade 1) at two years. 
Only the 3D pDD within the rectum was analysed. 
Our work has been divided in different steps: 
1. Registration 
Individuals' Computed Tomography (CT) from the planning and pDD 
were elastically registered using the demons algorithm to a single 
coordinate system by combining the CTs and organs delineations.  
2.Training step 
The training step consisted in learning from the data two vector 
subspaces spanning the 3D pDD of patients with toxicity and those of 
patients without toxicity, repectively. The different methods used to 
compute this subspaces have different constraints: orthogonality for 
Principal Component Analysis (PCA), mutual statistical independence 
for Independant Component Analysis (ICA). 
3.Validation 
A new patient was classified by evaluating its distances to this two 
subspaces. We computed the euclidean distance between this patient 
and it orthogonal projector in the two subspaces. Eventually, this 
patient is classified as toxic if the distance (dt) from the subspace 
representing toxic patients is less than the distance from the other 
subspace (dnt).  
4. Classification 
A leave-one-out cross validation and statistical measures - sensitivity 
and specificity - were used to evaluate the classification performance. 
The sensitivity assesses the percentage of toxic patients who are 
correctly identified as having toxicity. The specificity assesses the 
percentage of patients who are correctly identified as not having 
toxicity. 
Results: PCA method classified with 1 sensitivity and 0.76 specificity. 
ICA method allowed to classify perfectly rectal bleeding. Figure 1 
shows the distance represention of each patient for ICA method. Two 
significant clusters were identified. 
  
Conclusions: Our statistical approaches conjointly exploit 3D spatial 
patterns of dose. pDD and late rectal bleeding appear to be 
correlated. However, larger data base of patients will enable to use 
more robust classifiers. Our results will be compared with those 
obtained with existing models (i .e. NTCP).  
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Purpose/Objective: To validate the hypothesis that multi-centric 
learning produces better models than models built on data from 
individual centers only. 
Materials and Methods: We created an IT multi-centric network, 
which connects the databases of 5 clinical centers across 3 European 
countries. The network is a federated database where certain rules 
apply to ensure that data privacy is preserved, data never leaves the 
boundaries of its institution of origin, and secure traffic through 
firewalls is achieved. We then tested whether learning from federated 
data via the network gives advantage over single-center learning in 
the following way. A dataset 322 non-operable and non-metastatic 
non-small cell lung cancer patients treated with definite 
(chemo)radiotherapy was distributed with unequal proportions across 
5 centers.A model was built for each center using only the locally 
available data. A distributed learning model was deployed in the IT 
network which has a read-only, no-copy assess to local data. The 
chosen model was the Support Vector Machines (SVM) classifier, solved 
with the Alternating Direction Method of Multipliers method, which 
enables learning from data stored in different locations in a 
distributed way. The biggest advantage of this method is that the 
model learnt from scattered data across centers is exactly the same 
as if the data was centrally available. 
Results: The 5 centers had the following number of lung cancer 
patients available in the infrastructure: 186, 52, 45, 7 and 32, 
respectively. The predicted variable was 2-year survival, with 
predictor variables gender, World Health Organization performance 
status, forced expiratory volume in 1 second, number of positive 
lymph node stations, gross tumor volume and biologically-equivalent 
(at 2 Gray) total dose. No survival data was censored. We used the 
data at center 1 as an external validation set within the network. 
Model performance was evaluated using the area under the receiver 
operating characteristic curve (AUC). Models built separately on 
centers 2 to 5 had AUC's of 0.75, 0.68, 0.61 and 0.72 when validated 
on center 1. The AUC values fluctuate substantially, which reflects to 
a high degree the current model-learning reality and leaves open the 
question of how a combined-data model would perform. We can 
answer this question using the network: the distributed SVM model 
built on all data from centers 2 to 5 without any data leaving its origin 
had an AUC of 0.77 on center 1 (see Figure 1). 
